Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MDS Life Sciences Technology Fund was a prominent venture capital fund managed by MDS Capital Corp, the investment arm of the Canadian life sciences giant MDS Inc. The fund specialized in providing equity financing to early- and growth-stage companies within the biotechnology, medical device, and healthcare services sectors. It was instrumental in fostering the Canadian life sciences ecosystem during the late 1990s and early 2000s by bridging the gap between research and commercialization. Following a strategic restructuring of the parent company, the management team eventually transitioned to become Lumira Ventures. The fund successfully backed numerous companies that achieved significant clinical and commercial milestones in North America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MDS Life Sciences Technology Fund.